Login

Interview with Xspray Pharma - Per Andersson, CEO at Xspray Pharma 00:00:00

Share On Facebook Share On Twitter

Interview with Xspray Pharma - Per Andersson, CEO at Xspray Pharma

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Insights into Agricultural Credit and Financial Inclusion: Philippe Brassac Discusses Banking Strategies | Philippe Brassac, CEO, Crédit Agricole.
00:10:00
Magna Mining: Sudbury Nickel Exploration and Development Updates
00:10:00
Inside Australia's Leading Spiral Manufacturing Plant: A Showcase of Excellence | Andrew Foster, Managing Director of Mineral Technologies
00:10:00
Strategies for Attracting Investors: Insights from Northstar Group's Henky Prihatna | Henky Prihatna, Director, Northstar Group.
00:10:00
Turning Waste into Resource with Innovative Technology | Tim Stedman , CEO, Agilyx AS.
00:10:00
Williams Financial Group advocates for retirement protection, partnering with Protecting Your Retirement, LLC, in financial services.
00:10:00
Impact of JobKeeper and JobSeeker on Customers, Government's Role in Energy Sector, and Investment Uncertainty | Frank Calabria, CEO, Origin Energy Ltd .
00:10:00
Emanuele Galtieri at CyberSec2023: Navigating New Domains, Hybrid Wars, and Cooperation | Emanuele Galtieri, CEO, CY4Gate SpA.
00:10:00
Key Message from Michael Flanagan: Strategic Insights for Financial Planning | Michael Flanagan, General manager, Hyland Financial Planning.
00:10:00
Two IRA Mistakes Every Investor Should Avoid | Mike Palmer, Managing Principal , Ark Royal Wealth Management.
00:10:00
Strategic Insights with Intesa Sanpaolo's CEO on Future Challenges and Opportunities | Carlo Messina, CEO, Intesa Sanpaolo SpA.
00:10:00
China's Dominance in Rare Earth Processing: A National Security Risk

© 2017 - Neuhu+